Yukinori Kurokawa, Yuichiro Doki, Ryo Kitabayashi, Takaki Yoshikawa, Takashi Nomura, Kunihiro Tsuji, Masahiro Goto, Haruhiko Cho, Jun Hihara, Naoki Hiki, Souya Nunobe, Junki Mizusawa, Narikazu Boku, Masanori Terashima. Short-term outcomes of preoperative chemotherapy with docetaxel, oxaliplatin, and S-1 for gastric cancer with extensive lymph node metastasis (JCOG1704). Gastric Cancer. 2024.03; 27 (2): 366-374. ( PubMed, DOI )

Ikenaga N, Hashimoto T, Mizusawa J, Kitabayashi R, Sano Y, Fukuda H, Nakata K, Shibuya K, Kitahata Y, Takada M, Kamei K, Kurahara H, Ban D, Kobayashi S, Nagano H, Imamura H, Unno M, Takahashi A, Yagi S, Wada H, Shirakawa H, Yamamoto N, Hirono S, Gotohda N, Hatano E, Nakamura M, Ueno M, on behalf of the Hepatobiliary and Pancreatic Oncology Group in Japan Clinical Oncology Group. A multi-institutional randomized phase III study comparing minimally invasive distal pancreatectomy versus open distal pancreatectomy for pancreatic cancer; Japan Clinical Oncology Group study JCOG2202 (LAPAN study). BMC cancer. 2024.02; 24 (1): 231. ( PubMed, DOI )

Yuji Akiyama, Hitoshi Katai, Ryo Kitabayashi, Souya Nunobe, Keisuke Koeda, Masahiro Yura, Yuya Sato, Takaki Yoshikawa, Masanori Terashima. Frequency of lymph node metastasis according to tumor location in clinical T1 early gastric cancer: supplementary analysis of the Japan Clinical Oncology Group study (JCOG0912). Journal of Gastroenterology. 2023.06; 58 (6): 519-526. ( PubMed, DOI )

Ryo Kitabayashi, Hiroyuki Sato, Akihiro Hirakawa. Under-parameterized design with unit information prior in oncology basket trials. 2024 ENAR Spring Meeting 2024.03 Baltimore

Hironaga Satake, Kentaro Yamazaki, Yusuke Suwa, Takahiro Tsushima, Yasunobu Ishizuka, Shogen Boku, Atsuo Takashima, Toshifumi Yamaguchi, Masako Asayama, Mitsuru Yokota, Koji Numata, Takashi Ohta, Hisateru Yasui, Yosuke Kito, Yasumasa Takii, Ryo Kitabayashi, Yusuke Sano, Haruhiko Fukuda, Tetsuya Hamaguchi, Yukihide Kanemitsu. First report of the randomized phase III study of bi-weekly trifluridine/tipiracil (FTD/TPI) plus bevacizumab (BEV) vs. FTD/TPI monotherapy for chemorefractory metastatic colorectal cancer (mCRC): JCOG2014 (ROBiTS). ASCO GI 2024 2024.01 San Francisco

Yoshinori Imamura, Naomi Kiyota, Makoto Tahara, Takeshi Kodaira, Ryuichi Hayashi, Hiroshi Nishino. Yukinori Asada, Hiroki Mitani, Shigemichi Iwae, Naoki Nishio, Yusuke Onozawa, Nobuhiro Hanai, Akira Ohkoshi, Hiroki Hara, Nobuya Monden, Masato Nagaoka, Shujiro Minami, Ryo Kitabayashi, Keita Sasaki, and Akihiro Homma and the Head and Neck Cancer Study Group of the Japan Clinical Oncology Group (JCOG-HNCSG). Impact of Acute Kidney Injury on Overall Survival in Postoperative Patients with Head and Neck Cancer who Received Chemoradiotherapy with Cisplatin: A Supplementary Analysis of a Phase II/III Trial of JCOG1008. ASCO 2023 2023.06 Chicago

Yoshinori Imamura, Naomi Kiyota, Makoto Tahara, Takeshi Kodaira, Ryuichi Hayashi, Hiroshi Nishino. Yukinori Asada, Hiroki Mitani, Shigemichi Iwae, Naoki Nishio, Yusuke Onozawa, Nobuhiro Hanai, Akira Ohkoshi, Hiroki Hara, Nobuya Monden, Masato Nagaoka, Shujiro Minami, Ryo Kitabayashi, Keita Sasaki, and Akihiro Homma and the Head and Neck Cancer Study Group of the Japan Clinical Oncology Group (JCOG-HNCSG). A Risk Prediction Model for Cisplatin-induced Acute Kidney Injury in Head and Neck Cancer Patients who Received Chemoradiotherapy: A Supplement Analysis of a Phase II/III Trial of JCOG1008. ASCO 2023 2023.06 Chicago

Takaki Yoshikawa, Yukinori Kurokawa, Ryo Kitabayashi, Junki Mizusawa, Takashi Nomura, Kurihiro Tsuji, Ryo Tanaka, Haruhiko Cho, Jun Hihara, Naoki Hiki, Souya Nunobe, Narikazu Boku, Yuichiro Doki, Masanori Terashima, Stomach Cancer Study Group of Japan Clinical Oncology Group (JCOG). A phase II study of preoperative chemotherapy with docetaxel, oxaliplatin, and S-1 followed by D2 plus para-aortic nodal dissection for gastric cancer with extensive lymph node metastasis: JCOG1704. ASCO GI 2023 2023.01 San Francisco